Alimta

... PharmaLive: US Oncology Research Network Presents Clinical Studies at ASCO Gastrointestinal Cancers Symposium REGISTERED USERS TODAY ON PHARMALIVE.COM US Oncology Research Network Presents Clinical Studies at ASCO Gastrointestinal Cancers Symposium Clinical Studies to Show Results of Phase II Trials for Treatment of Hepatoma and Pancreatic Cancer HOUSTON, January 30, 2006 /PRNewswire/ - Leading cancer researchers affiliated with the US Oncology Research Network presented findings from a Phase II clinical study testing single agent pemetrexed in patients with advanced and metastatic hepatoma (primary liver cancer), and a phase II clinical study testing gemcitabine plus zoledronic acid on subjects with Stage IV pancreatic cancer.

The findings were presented at the 2006 Gastrointestinal Cancers Symposium Jan.

26-28 in San Francisco by physicians affiliated with US Oncology, Inc., one of the nation's largest health care services networks focused exclusively on cancer treatment and research.

"We are pleased to announce the findings of this research at this important conference," said Dr.

Thomas Cartwright of Ocala Oncology, an affiliate of US Oncology, Inc.

"Every opportunity we have to present our research and discuss our efforts with other experts in the field is an opportunity to advance the science of cancer research." The presentations included: Single-agent pemetrexed in patients with advanced and metastatic hepatoma Researchers: Allen L.

Cohn, M.D., Rocky Mountain Can...

Read more...